Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: ProteinLogic Ltd
Street 1: Shakespeare House
Street 2: 42 Newmarket Road
City: Cambridge
Province: Cabmridgeshire
Post Code: CB5 8EP
Country: United Kingdom of Great Britain and Northern Ireland
Phone: +447789606850
Organization Email:
Web Site:
Other Online Presence:

Focal Point Contact Information

Salutation: Dr
First Name: Nicolas
Last Name: Huber
Title: CEO

Alternate Focal Point Contact Information

Salutation: Mrs
First Name: Darleen
Last Name: Welford
Title: VP QA/RA

General Information

Board Constituency: None
Is your organization legally registered in your country: Yes
If yes, please enter your registration number:
Organization Type - Primary: Private Sector
Organization Type - Secondary: Company
Organization Description:
ProteinLogic Ltd (PL) is a biomarker discovery and exploitation company developing a novel diagnostic platform and diagnostic products with broad clinical utility. The company was founded in 2003 in Cambridge, UK, based on the work of Nobel laureate C├ęsar Milstein.

ProteinLogic has developed an immunoassay diagnostic for the ruling out of Active TB from a blood sample. ProteinLogic has validated this diagnostic signature with over 1000 high quality, prospectively collected, ethnically diverse TB patient samples, our results exceeding the WHO mandated performance criteria of 90% sensitivity and 70% specificity, including for extra-pulmonary TB cases.
Do you know about the UNHLM declaration:

Specializations / Areas of Work

Research and Development

Other Organization Information

Total number of staff in your organization: 1 - 5
Number of full-time staff who are directly involved with TB: 1 - 5
Number of part-time staff who are directly involved with TB: 1 - 5
Number of volunteers who are directly involved with TB: 0
How did you hear about the Stop TB Partnership: Internet search
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Information on developments within the TB world
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: No
Please tell us how your organization is contributing to your country's national TB control plan:
We are based in the UK, which is a low burden country. However, with the focus on the eradication of TB in the UK, our unique test can help with the faster diagnosis of extra-pulmonary TB cases, which are of unusually high prevalence in the UK.

Geographical Reach

Which country is your headquarters located in: United Kingdom of Great Britain and Northern Ireland
Which countries do you do operate in:
(This includes countries you are conducting activities in)
South Africa
United Kingdom of Great Britain and Northern Ireland


Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

Laboratory Strengthening:
Our test can be deployed in a laboratory setting. At this moment in time, we have no activities in this area yet.

New Diagnostics:
ProteinLogic is collecting clinical samples from Spain, Brazil and South Africa for the further validation of its novel active TB rule-out test. We expect completion of collection to be by end of 2018, with evaluation of the results within the first half of 2019.


Declaration of interests:
We are a commercial entity, with the aim of developing new diagnostics for TB. No specific conflicts beyond this are known.

Application date: October 8, 2018
Last updated: October 8, 2018